The only approved equine PSGAG.

As the only approved equine PSGAG (polysulfated glycosaminoglycan) for degenerative joint disease (DJD) in horses, Adequan® I.M. actually treats DJD, not just its clinical signs.1,2,4 For over 30 years*, Adequan® I.M. has been administered by veterinarians to help horses of every discipline and level enjoy greater mobility over their lifetimes.1,3,4

*Includes U.S. Approval

Horse running in stable

INDICATIONS

Adequan® I.M. is recommended for the treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness in horses.

How To Use Graph How To Use Graph

Treat the disease, not just the clinical signs of DJD.

Adequan® I.M. is unlike any other equine joint product. It’s been proven to work in multiple ways to maintain joint function:3,4

  • Reduce inflammation
  • Restore synovial joint lubrication
  • Repair joint cartilage
  • Reverse the disease process

The benefits of
accurate dosing.

When administered at the recommended label dose, Adequan® I.M. not only reaches joints quickly, but also helps to protect and renew joint mobility.1,3

Adequan® I.M. Polysulfated Glycosaminoglycan Sterile Injection 100 mg/mL
INDICATIONS
Adequan® I.M. is recommended for the treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness in horses.
IMPORTANT SAFETY INFORMATION
Adequan® I.M. is for veterinary use only. The prescribing information contains complete use information which includes dosing, contraindications, warnings and cautions. Always read, understand and follow label and use directions. PLEASE CONSULT the Full Prescribing Information.
1. Kim DY, Taylor HW, Moore RM, Paulsen DB, Cho DY. Articular chondrocyte apoptosis in equine osteoarthritis. The Veterinary Journal 2003; 166: 52-57.
2. McIlwraith CW, Frisbie DD, Kawcak CE, van Weeren PR. Joint Disease in the Horse. St. Louis, MO: Elsevier, 2016; 33-48.
3. Burba DJ, Collier MA, DeBault LE, Hanson-Painton O, Thompson HC, Holder CL: In vivo kinetic study on uptake and distribution of intramuscular tritium-labeled polysulfated glycosaminoglycan in equine body fluid compartments and articular cartilage in an osteochondral defect model. J Equine Vet Sci 1993; 13: 696-703.
4. Adequan® I.M. (polysulfated glycosaminoglycan sterile injection 100 mg/mL), Package Insert IN99501C. American Regent, Inc.
CONTACT INFORMATION
Contact Us Adverse Event Reporting Product Quality Complaints
MORE ABOUT ADEQUAN
Dosing & Administration Prescribing Information Ordering Information
AMERICAN REGENT ANIMAL HEALTH
About Us Our Brands Privacy Settings
Animal Health Logo
All trademarks are the property of American Regent, Inc.
© 2023, American Regent, Inc.
PP-AI-CA-0004 (v2.0)